The Company considers it as our mission to operate the business focusing on the profits of our shareholders and all the other stakeholders (employees, business partners, patients, creditors, local communities, etc.) under the Company policy of contributing to the world health care. For that purpose, it is inevitable that our business will develop steadily and continuously. The Company recognizes it as an important management issue and has been proactively promoting it to enhance corporate governance for the purpose of improving soundness and transparency of management that is the basis of such development.
We submit "Corporate Governance Report" to the Tokyo Stock Exchange.